正文翻译排队
该来源正文已进入翻译队列，中文正文生成前先展示摘要和原始出处入口。
摘要
The European Medicines Agency is taking what advocacy groups are calling unexpectedly “rapid action” to ensure that clinical trial results are made public as required by law.
STAT+: European regulators take steps to bolster clinical trial transparency
The European Medicines Agency is taking what advocacy groups are calling unexpectedly “rapid action” to ensure that clinical trial results are made public as required by law.